Cambrex will be attending MEDevice in Boston this fall. Mark your calendar for September 25-26 at the Boston Convention & Exhibition Center. Click the link to schedule a meeting: https://lnkd.in/ga6nfGnC #MEDeviceBoston #ConnectWithCambrex
About us
Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical and IND enabling services. With over 40 years of experience and a growing team of over 2,000 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing.
- Website
-
http://www.cambrex.com
External link for Cambrex
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- East Rutherford, New Jersey
- Type
- Privately Held
- Specialties
- Drug substance services, Drug product services, and Analytical services
Locations
Employees at Cambrex
-
Dottie Donnelly Brienza
CHRO | C-Suite Leadership Alignment | Culture Building | HR Strategy | Talent Management | M&A | Change Management | OD
-
Rob Duncan
Senior Talent Acquisition Partner at Cambrex; seeking talent in Quality Control, Analytical Development, Chemical Development, Commercial, and…
-
Cara Wykowski
Director, Business DevelopmentCertified at Cambrex; Certified Peer to Peer Grief Educator
-
Hamid Parsa
Drug Substance BU Vice President Sales and Business Development Europe/Asia
Updates
-
Don't miss this third annual Stability Studies Conference hosted by Q1 Scientific taking place October 17th just outside of Dublin, Ireland. This event brings together industry experts sharing their insights on the latest trends and best practices in stability studies and product development. 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄 𝗮𝗻𝗱 𝘀𝗲𝗰𝘂𝗿𝗲 𝘆𝗼𝘂𝗿 𝘀𝗽𝗼𝘁: https://lnkd.in/gdPQZHGE
𝗝𝗼𝗶𝗻 𝘂𝘀 𝗮𝘁 𝗦𝘁𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗦𝘁𝘂𝗱𝗶𝗲𝘀 𝟮𝟬𝟮𝟰 𝗰𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲, 𝗵𝗼𝘀𝘁𝗲𝗱 𝗯𝘆 𝗤𝟭 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 We’re excited to announce the third annual Stability Studies Conference, taking place on 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟭𝟳𝘁𝗵, 𝟮𝟬𝟮𝟰 at the 𝗞𝗶𝗹𝗹𝗮𝘀𝗵𝗲𝗲 𝗛𝗼𝘁𝗲𝗹, 𝗡𝗮𝗮𝘀. This is your chance to connect with industry leaders, network with your peers, explore real-world examples, lessons learned and best practices from leading experts in stability studies. Whether you’re a Stability Programme Manager, Analytical Chemist, Research Scientist, QC/QA Professional, or Regulatory Affairs expert, this conference is designed to help you excel in your role. 𝗙𝗲𝗮𝘁𝘂𝗿𝗲𝗱 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: ◼️ Dr. Mark Powell - Director at MP Scientific ◼️ Nuala Calnan, PhD - CEO of BioPharm Excel, Founder of the The Quality Risk Management Institute, and Adjunct Research Fellow at TU Dublin ◼️ Stan O'Neill - Managing Director of The Compliance Group ◼️ Catherine McHugh - Owner and Director of Imbolc Pharma Consulting ◼️ Kate Coleman - Vice President Regulatory Affairs, Quality and Compliance (Principal Consultant) at Arriello ◼️ Stephen Delaney - Managing Director at Q1 Scientific Don’t miss out on this opportunity to elevate your expertise and gain a deeper understanding of regulatory requirements. 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄 𝗮𝗻𝗱 𝘀𝗲𝗰𝘂𝗿𝗲 𝘆𝗼𝘂𝗿 𝘀𝗽𝗼𝘁: https://lnkd.in/g4eingk2 #StabilityStudies #Pharmaceutical #MedicalDevice #StabilityStudies2024 #Networking #ProfessionalDevelopment
-
-
Extractables and leachables (“E&L”) studies are an essential component of regulatory filing to demonstrate product safety. Depending on the container-closure system or medical device being evaluated, E&L studies can be very complex. Choosing a CDMO with expertise is critical to successful delivery of robust E&L data that you can trust. Read our whitepaper to learn more about the criticality of E&L studies when it comes to patient safety and how Cambrex’s analytical services offerings can help address your program needs. https://lnkd.in/g6z66Drd #EandL #Pharma #AnalyticalTesting #CDMO
WHITEPAPER | Extractables & Leachables: Solutions for Risk Management and Analytical Testing
https://www.cambrex.com
-
#CPHIMilan 2024 is quickly approaching. Both the Cambrex and Snapdragon Chemistry teams are looking forward to meeting you in Milano, Italy! Click the link to schedule a meeting 8-10 October at stand # 5B1: https://lnkd.in/gj28bNA3 #CPHI #AtTheHeartOfPharma #CDMO #Pharma #Manufacturing #PharmaceuticalIndustry
-
-
Attending American Chemical Society's National Fall Meeting in Denver, CO next week? Don't miss the opportunity to hear from our Snapdragon Chemistry #ContinuousFlow experts.
We're excited to be part of American Chemical Society's National Fall Meeting in Denver, CO next week. Mark your calendar to attend these presentations from our #ContinuousFlow experts: "Continuous Flow as Enabling Technology for Intrinsically Hazardous Chemistry: Diazotization, Azidation, and Click Chemistry with an Explosive Alkyne" | August 19, 2:40 PM – 3:15 PM | Mile High Ballroom 4C | Presented by Adrian Amador, Ph.D., Director of Chemistry "Scalable On-demand Production of Tetrafluoroethylene for Fluoroalkylations in Continuous Flow" | August 21, 7:00 PM - 9:00 PM | Hall A-C | Presented by Evan Hurlow, Ph.D., Scientist, Process R&D #ACSFall2024
-
-
Cambrex is excited to be back at Nordic Life Science Days next month. The Cambrex team is looking forward to meeting you face-to-face in Malmö! Click the link to schedule a meeting -> Hamid Parsa and Gianluca Di Lernia -> https://lnkd.in/eQZCUqYM #NLSdays #CDMO #ConnectWithCambrex
Connect with Cambrex
https://www.cambrex.com
-
We're thrilled to be part of American Chemical Society's National Fall Meeting in Denver, CO next week. You don't want to miss these sessions: "Addressing Solvent Limitations and Exothermic Character of Nitroarene Reduction by Diboron Reagents" | August 18, 7:00 PM - 9:00 PM; Poster 4105493 “Expanding Scope and Application of Chemoselective Aromatic Nitro Reductions by Tetrahydroxydiboron” | August 18, 7:00 PM - 9:00 PM; Poster 4106042 “Understanding the Drug Development Process, Life Cycle, and Project Team in the Transition from Discovery to Early Chemical Development: The Nuts and Bolts of IND-Enabling Research” | August 18, 7:00 PM - 9:00 PM; Poster 4109668 “Process Development and Kilogram-scale Demonstration of Nitroarene Reduction by Tetrahydroxydiboron” | August 19, 8:00 PM - 10:00 PM; Poster 4106081 “Accelerating Phase-Appropriate Drug Substance (API) Development: A Case Study Review of Strategic Decisions, Pitfalls and Science Behind Early Phase Development” | August 20, 4:35 PM - 5:00 PM Presented by: Aliakbar Mohammadlou, PhD, Amber Rydholm, Ph.D., Amy Taylor, Bradley Rose, Cy Credille, Derek Burnet M.S., Derrick Juengst, James Graham, Kerrick C. Rees, PhD, Kimberly Casalvieri, Matthew Haynes, Morris Dweck, Saeedeh Torabi Kohlbouni, Sara F., Tracy Milburn #ACSFall2024 #CDMO #ConnectWithCambrex
-
-
Attending ChemOutsourcing next month? Connect with the Cambrex team at the Parsippany Hilton throughout #ChemOutsourcing Week. Click the link to schedule a meeting -> Mark Eugenio, Michael Mrvos, and Jason Blanchard -> https://lnkd.in/gdW2buyw #CDMO #ConnectWithCambrex
Connect with Cambrex
https://www.cambrex.com
-
Continuous chemical manufacturing technology has been in use for more than 100 years producing high-volume commodity chemicals. However, it was not until the early 2000s that the technology caught the attention of the pharmaceutical industry in a significant way, and it has since revolutionized the production of pharmaceuticals. In our recent article published in European Pharmaceutical Review, Matthew Bio, Chief Scientific Officer at Cambrex, discusses how continuous manufacturing has become integral to the pharmaceutical industry. Read the full article here: https://lnkd.in/eBp4nxn2
Continuous Manufacturing: An Evolving Technology | Cambrex
https://www.cambrex.com
-
Peptide crystallization introduces greater complexity due to molecular flexibility and size. Each peptide requires unique insight to optimize individual conditions. Trust the team at Cambrex to deliver reliable, scalable results. We leverage the right tools with the best experts to bridge success from the bench to the plant. Learn more here: https://lnkd.in/gbn7K3t5 #peptides #crystallization #pharma
CDMO | Peptide Crystallization | Cambrex
https://www.cambrex.com